BIOR241220C2000
- 0.00
- 0.000.00%
Biora Therapeutics Newsroom
Express News | HC Wainwright & Co. Maintains Buy on Biora Therapeutics, Adjusts Price Target To $23 (1-10 Reverse Stock Split)
Biora Therapeutics Analyst Ratings
Express News | Biora Therapeutics Shares Are Trading Lower. The Stock May Be Moving on Continued Weakness Following a Q3 Earnings Miss and a Year-over-year Decline in Revenue Reported on Thursday
Biora Therapeutics | 10-Q: Q3 2024 Earnings Report
Biora Therapeutics | 8-K: Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
Express News | Highbridge Capital Management, LLC Reports 9.99% Passive Stake in Biora Therapeutics Inc as of Sept 30, 2024- SEC Filing
Here Are the Major Earnings After the Close Today
Biora Therapeutics Reports Q3 EPS ($5.04) Vs (35c) Last Year
Earnings Flash (BIOR) BIORA THERAPEUTICS Posts Q3 Revenue $32,000
Biora Therapeutics 3Q Loss/Shr $5.04 >BIOR
Earnings Scheduled For November 14, 2024
Biora Therapeutics's Earnings Outlook
Earnings Preview: BIOR to Report Financial Results Post-market on November 14
Express News | Biora Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update
Biora Therapeutics Stock Falls as It Looks to Raise $3M via Direct Offering
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Express News | Biora Therapeutics Inc - to Issue Warrants for 745,342 Shares at $3.90 Each
Express News | Biora Therapeutics Announces $3 Million Registered Direct Offering Priced at-the-Market Under Nasdaq Rules
Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Press Release: Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules